Evidence map›Paper›PMID 35008545›Full record

ArticleInternational journal of molecular sciences2021

The Effect of Fullerenol C

Jacek Grebowski, Paulina Kazmierska-Grebowska, Natalia Cichon, Piotr Piotrowski, Grzegorz Litwinienko

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. DFT Study of NO and NOMolecules (Basel, Switzerland) · 2026
    Article
  2. Metallofullerenol ScAdvanced healthcare materials · 2026
    Article
  3. Article
  4. Article
  5. Fullerenol CAntioxidants (Basel, Switzerland) · 2024
    Article
  6. Influence of CCancers · 2023
    Article
  7. Article
  8. Fullerenol CInternational journal of molecular sciences · 2022
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jacek GrebowskiDepartment of Molecular Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.ORCID 0000-0001-5407-9533
Paulina Kazmierska-GrebowskaDepartment of Neurobiology, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.
Natalia CichonBiohazard Prevention Centre, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.ORCID 0000-0002-0139-2451
Piotr PiotrowskiFaculty of Chemistry, University of Warsaw, Pasteura 1, 02-093 Warsaw, Poland.ORCID 0000-0003-4245-0125
Grzegorz LitwinienkoFaculty of Chemistry, University of Warsaw, Pasteura 1, 02-093 Warsaw, Poland.ORCID 0000-0002-5523-0888
University of Łódź · PLUniversity of Warsaw · PL

Funding

National Science Center 2019/35/D/ST4/02627
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntioxidantsErythrocytesFullerenesGlutathione PeroxidaseGlutathione ReductaseHumansOxidation-ReductionOxidative StressReactive Oxygen SpeciesSulfhydryl CompoundsAntioxidantsFullerenesfullerenolGlutathione PeroxidaseGlutathione ReductaseReactive Oxygen SpeciesSulfhydryl Compoundsantioxidanterythrocytesfullerenoloxidative stresswater-soluble derivatives of fullerenes

Identifiers

PMID35008545
PMCPMC8744983
OpenAlexW4200391962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.